TEVA Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: TEVA's partnership with Immunai and positive trial results signal growth in innovative drug pipelines. Elevated bullish option volumes suggest increased investor confidence.




Bearish Case: TEVA faces ongoing litigation risks and historical underperformance, maintaining downward pressure. High put option volumes and implied volatility reflect market caution.




Potential Outcomes:
  • 40%: Price rebounds to $24 due to innovative partnerships.
  • 35%: Price stagnates around $20 amid ongoing litigation.
  • 25%: Price declines to $17 due to market pressures.




Trading Oracle: Execute a bullish strategy using debit spreads, buying TEVA 22.00C and selling TEVA 24.00C. This exploits the current volatility landscape and anticipates price movement upwards. Optimal timeframe: 6 months, focusing on capturing upside potential indicated by high option volumes.



January 22, 2025


Teva- Pharmaceutical Industries Forecast

TEVA        Teva- Pharmaceutical Industries
















Become a more profitable investor with AI optimized trading strategies






×

Chat with TEVA


 Ask any question about TEVA!